Zevra Therapeutics, Inc. · NASDAQ:ZVRA
Woodline Partners LP reported a 6.20% stake in Zevra Therapeutics, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Woodline Partners LP reported a 6.20% stake in Zevra Therapeutics, Inc., 3,476,143 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 6.20%
- Shares
- 3,476,143
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Woodline Partners LP | 6.20% | 3,476,143 |
Source
Related
- Zevra Therapeutics, Inc.
- Woodline Partners LP
- Zevra Therapeutics, Inc. shareholders
- Schedule 13G/A · Woodline Partners LP · Aug 14, 2026
- Form 4 · McFarlane Neil F. · Oct 13, 2026
- Form 4 · Thompson Rahsaan · Aug 17, 2026
- Form 4 · Watton Corey Michael · Aug 12, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026